Bonus depreciation has long been a powerful tool in the tax strategy arsenal of real estate investors. As we move through 2025, the rules around bonus depreciation are shifting, and staying informed is crucial for optimizing your tax outcomes. What Is Bonus Depreciation? Bonus depreciation is a tax incentive that allows businesses, including real estate […]
Read More
The IRS has issued Revenue Procedure 2025-28, providing long-awaited guidance on how businesses must handle research and experimental (R&E) expenditures following the One Big Beautiful Bill Act (OBBBA). These rules affect how domestic research costs are deducted or amortized, and they include special provisions for small businesses. What Changed Under OBBBA? Previously, Section 174 required […]
Read More
The bioscience industry thrives on innovation, from groundbreaking pharmaceuticals and medical devices to agricultural biotechnology and diagnostic tools. But innovation is expensive, and many companies don’t realize they can recover a significant portion of those costs through the Research and Development (R&D) Tax Credit. For bioscience companies, this incentive can improve cash flow, fund future […]
Read More
The “Big Beautiful Bill,” delivers a major win for businesses investing in innovation. One of its most significant provisions affects how research and development (R&D) expenses are treated for tax purposes, reversing one of the more burdensome changes from the Tax Cuts and Jobs Act (TCJA). Here’s what you need to know about how OBBBA […]
Read MoreHave a question or need assistance? One of our team members will be in touch within the next business day.
